Evidence map›Paper›PMID 37786737›Full record

ReviewIbrain2022

Potential natural products for the management of autism spectrum disorder.

Punya Sachdeva, Intizaar Mehdi, Rohit Kaith, Faizan Ahmad, Md Sheeraz Anwar

Abstract readReview
In one paragraph

Review in Ibrain, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Protective Effects of PrenatalMolecules (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Punya SachdevaAmity Institute of Neuropsychology and Neurosciences Amity University Noida Uttar Pradesh India.ORCID 0000-0001-9967-1872
Intizaar MehdiSchool of Studies in Neuroscience Jiwaji University Gwalior Madhya Pradesh India.
Rohit KaithSchool of Studies in Neuroscience Jiwaji University Gwalior Madhya Pradesh India.
Faizan AhmadDepartment of Medical Elementology and Toxicology Jamia Hamdard University Delhi India.
Md Sheeraz AnwarDepartment of Psychology University of Campania Luigi Vanvitelli Caserta Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism in a broader sense is a neurodevelopmental disorder, which frequently occurs during early childhood and can last for a lifetime. This condition is primarily defined by difficulties with social engagement, with individuals displaying repetitive and stereotyped behaviors. Numerous neuroanatomical investigations on autistic children have revealed that their brains grow atypically, resulting in atypical neurogenesis, neuronal migration, maturation, differentiation, and degeneration. Special education programs, speech therapy, and occupational therapy have all been used to address autism-related behavioral problems. While widely prescribed antidepressant drugs, antipsychotics, anticonvulsants, and stimulants have demonstrated response in autistic individuals. However, these medications do not fully reverse the core symptoms associated with autism spectrum disorder (ASD). The adverse reactions of ASD medicines and an increased risk of developing various other problems, such as obesity, dyslipidemia, diabetes mellitus, and thyroid disorders, prompted the researchers to investigate herbal medicines for the treatment of autistic individuals. Clinical trials are now being done to establish the efficacy of alternative techniques based on natural substances and to understand better the context in which they may be used to treat autism. This review of literature will look at crucial natural compounds derived from animals and plants that have shown promise as safe and effective autism treatment strategies.

Indexed as

autismdietary supplementnatural productsneurodevelopmental disorderneurotherapeutics

Identifiers

PMID37786737
PMCPMC10528773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.